PNC Financial Services Group
CUE icon

PNC Financial Services Group’s Cue Biopharma CUE Stock Holding History

PNC Financial Services Group’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3
Closed – – 4529
2022
Q1 		$0 Hold
3
– – ﹤0.01% 4556
2021
Q4 		$2K Hold
3
– – ﹤0.01% 4136
2021
Q3 		$2K Hold
3
– – ﹤0.01% 4091
2021
Q2 		$2K Hold
3
– – ﹤0.01% 4023
2021
Q1 		$2K Hold
3
– – ﹤0.01% 3941
2020
Q4 		$2K Hold
3
– – ﹤0.01% 3821
2020
Q3 		$2K Hold
3
– – ﹤0.01% 3798
2020
Q2 		$2K Hold
3
– – ﹤0.01% 3757
2020
Q1 		$2K Hold
3
– – ﹤0.01% 3718
2019
Q4 		$2K Hold
3
– – ﹤0.01% 3773
2019
Q3 		$0 Hold
3
– – ﹤0.01% 4005
2019
Q2 		$0 Hold
3
– – ﹤0.01% 4032
2019
Q1 		$0 Hold
3
– – ﹤0.01% 4043
2018
Q4 		$0 Hold
3
– – ﹤0.01% 4061
2018
Q3 		$0 Hold
3
– – ﹤0.01% 4129
2018
Q2 		$2K Hold
3
– – ﹤0.01% 3973
2018
Q1 		$2K Buy
+3
New +$1.37K ﹤0.01% 4023

Other funds holding CUE

PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

PNC Financial Services Group's CUE Position: Q2 2022 in Review

PNC Financial Services Group sold out of Cue Biopharma (CUE) in Q2 2022, closing a stake of 3 shares.

PNC Financial Services Group first reported a position in CUE in Q1 2018 and held it in 17 quarters. The position peaked at $2K in Q4 2021. 75 funds tracked by Wall St. Rank hold CUE as of Q2 2022.

  • PNC Financial Services Group reported no remaining Cue Biopharma position as of Q2 2022 after selling out during the quarter.
  • PNC Financial Services Group sold 3 Cue Biopharma shares in Q2 2022.
  • PNC Financial Services Group first reported a position in Cue Biopharma in Q1 2018 and held it in 17 quarters.
  • PNC Financial Services Group's Cue Biopharma position peaked at $2K in Q4 2021.
  • 75 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2022.

Based on PNC Financial Services Group's 13F filing for Q2 2022, filed 12 Aug 2022.